Vidal-Puig A J, Considine R V, Jimenez-Liñan M, Werman A, Pories W J, Caro J F, Flier J S
Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.
J Clin Invest. 1997 May 15;99(10):2416-22. doi: 10.1172/JCI119424.
The peroxisome proliferator activated receptor (PPAR gamma) plays a key role in adipogenesis and adipocyte gene expression and is the receptor for the thiazolidinedione class of insulin-sensitizing drugs. The tissue expression and potential for regulation of human PPAR gamma gene expression in vivo are unknown. We have cloned a partial human PPAR gamma cDNA, and established an RNase protection assay that permits simultaneous measurements of both PPAR gamma1 and PPAR gamma2 splice variants. Both gamma1 and gamma2 mRNAs were abundantly expressed in adipose tissue. PPAR gamma1 was detected at lower levels in liver and heart, whereas both gamma1 and gamma2 mRNAs were expressed at low levels in skeletal muscle. To examine the hypothesis that obesity is associated with abnormal adipose tissue expression of PPAR gamma, we quantitated PPARgamma mRNA splice variants in subcutaneous adipose tissue of 14 lean and 24 obese subjects. Adipose expression of PPARgamma 2 mRNA was increased in human obesity (14.25 attomol PPAR gamma2/18S in obese females vs 9.9 in lean, P = 0.003). This increase was observed in both male and females. In contrast, no differences were observed in PPAR gamma1/18S mRNA expression. There was a strong positive correlation (r = 0.70, P < 0.001) between the ratio of PPAR gamma2/gamma1 and the body mass index of these patients. We also observed sexually dimorphic expression with increased expression of both PPAR gamma1 and PPAR gamma2 mRNAs in the subcutaneous adipose tissue of women compared with men. To determine the effect of weight loss on PPAR gamma mRNA expression, seven additional obese subjects were fed a low calorie diet (800 Kcal) until 10% weight loss was achieved. Mean expression of adipose PPAR gamma2 mRNA fell 25% (P = 0.0250 after a 10% reduction in body weight), but then increased to pretreatment levels after 4 wk of weight maintenance. Nutritional regulation of PPAR gamma1 was not seen. In vitro experiments revealed a synergistic effect of insulin and corticosteroids to induce PPAR gamma expression in isolated human adipocytes in culture. We conclude that: (a) human PPAR gamma mRNA expression is most abundant in adipose tissue, but lower level expression of both splice variants is seen in skeletal muscle; to an extent that is unlikely to be due to adipose contamination. (b) RNA derived from adipose tissue of obese humans has increased expression of PPAR gamma 2 mRNA, as well as an increased ratio of PPAR gamma2/gamma1 splice variants that is proportional to the BMI; (c) a low calorie diet specifically down-regulates the expression of PPAR gamma2 mRNA in adipose tissue of obese humans; (d) insulin and corticosteroids synergistically induce PPAR gamma mRNA after in vitro exposure to isolated human adipocytes; and (e) the in vivo modulation of PPAR gamma2 mRNA levels is an additional level of regulation for the control of adipocyte development and function, and could provide a molecular mechanism for alterations in adipocyte number and function in obesity.
过氧化物酶体增殖物激活受体(PPARγ)在脂肪生成和脂肪细胞基因表达中起关键作用,是噻唑烷二酮类胰岛素增敏药物的受体。人类PPARγ基因在体内的组织表达及调控潜力尚不清楚。我们克隆了部分人类PPARγ cDNA,并建立了一种核糖核酸酶保护分析方法,可同时检测PPARγ1和PPARγ2剪接变体。γ1和γ2 mRNA在脂肪组织中均大量表达。在肝脏和心脏中检测到较低水平的PPARγ1,而在骨骼肌中γ1和γ2 mRNA均低水平表达。为检验肥胖与PPARγ在脂肪组织中的异常表达相关这一假说,我们对14名瘦人和24名肥胖受试者皮下脂肪组织中的PPARγ mRNA剪接变体进行了定量分析。在人类肥胖状态下,PPARγ2 mRNA的脂肪组织表达增加(肥胖女性中为14.25阿托摩尔PPARγ2/18S,瘦人则为9.9,P = 0.003)。在男性和女性中均观察到这种增加。相比之下,PPARγ1/18S mRNA表达未观察到差异。这些患者的PPARγ2/γ1比值与体重指数之间存在强正相关(r = 0.70,P < 0.001)。我们还观察到性别差异表达,与男性相比,女性皮下脂肪组织中PPARγ1和PPARγ2 mRNA的表达均增加。为确定体重减轻对PPARγ mRNA表达的影响,另外7名肥胖受试者接受低热量饮食(800千卡),直至体重减轻10%。体重减轻10%后,脂肪组织中PPARγ2 mRNA的平均表达下降25%(P = 0.0250),但在体重维持4周后又回升至预处理水平。未观察到对PPARγ1的营养调控作用。体外实验显示,胰岛素和皮质类固醇在体外培养的分离人类脂肪细胞中具有协同诱导PPARγ表达的作用。我们得出以下结论:(a)人类PPARγ mRNA表达在脂肪组织中最为丰富,但在骨骼肌中两种剪接变体均有较低水平表达;其程度不太可能是由于脂肪污染所致。(b)肥胖人类脂肪组织来源的RNA中PPARγ2 mRNA表达增加,以及PPARγ2/γ1剪接变体比值增加,且与体重指数成正比;(c)低热量饮食可特异性下调肥胖人类脂肪组织中PPARγ2 mRNA的表达;(d)胰岛素和皮质类固醇在体外暴露于分离的人类脂肪细胞后可协同诱导PPARγ mRNA;(e)PPARγ2 mRNA水平的体内调节是控制脂肪细胞发育和功能的另一调控层面,可能为肥胖状态下脂肪细胞数量和功能改变提供分子机制。